Effects of membrane lipids on the incorporation of Alzheimer's β-amyloid protein into membranes and neurotoxicity

膜脂对阿尔茨海默病β-淀粉样蛋白掺入膜的影响和神经毒性

基本信息

项目摘要

It is widely accepted that the neurotoxicity of β-amyloid protein (AβP) is implicated in the etiology of Alzheimer's disease. We have previously shown that AβP is directly incorporated into membranes, forms cation-selective ion channels, and causes an increase in intracellular calcium levels of immortalized hypothalamic neurons. We hypothesize that the disruption of calcium homeostasis through the unregulated amyloid channels may be the primary event of neuro-toxicity of AβP. In this study, we investigated the detailed characteristics of the increase in intracellular calcium levels of primary cultured rat hippocampal neurons caused by AβP using a multisite fluorometry system. We found and report here that AβP caused a marked increase in intracellular calcium levels of long-term (more than three weeks)-cultured rat hippocampal neurons, but not in short-term (less than 2 weeks)-cultured neurons. The responses of neurons to AβP were highly heterogeneous. Immunohistochemical observation revealed that some restricted neurons have an affinity to the AP. To determine the substances that can confer protection against the neurotoxicity of AβP, we preadministerated dehydroepiandrosterone sul-phate (DHEA-S), whose levels in the serum of elderly are reduced, and found a significant inhibition of the increase in intracellular calcium levels induced by AβP. Our results suggest the implication of the ability of AβP to form amyloid channels may be based on the Alzheimer's pathogenesis. It is also possible that the endogenous substances such as DHEA-S may con-tribute to the prevention from the neurotoxicity of AβP.
β-淀粉样蛋白(β-amyloid protein,AβP)的神经毒性与阿尔茨海默病的发病机制密切相关。我们以前已经证明,AβP直接掺入膜,形成阳离子选择性离子通道,并导致永生化下丘脑神经元细胞内钙水平升高。我们推测,通过不受调节的淀粉样蛋白通道破坏钙稳态可能是AβP神经毒性的主要事件。本研究采用多点荧光法研究了AβP引起原代培养大鼠海马神经元胞内钙离子浓度升高的详细特征。我们发现并报道,AβP可引起长期(3周以上)培养的大鼠海马神经元细胞内钙水平显著升高,但对短期(2周以下)培养的神经元无明显影响。神经元对AβP的反应具有高度异质性。免疫组织化学观察显示,部分限制性神经元与AP有亲和力。为了确定可以对抗AβP神经毒性的物质,我们预先给予硫酸脱氢表雄酮(DHEA-S),其在老年人血清中的水平降低,并发现显着抑制AβP诱导的细胞内钙水平升高。我们的结果提示AβP形成淀粉样蛋白通道的能力可能与阿尔茨海默病的发病机制有关。内源性物质如DHEA-S也可能对AβP的神经毒性起预防作用。

项目成果

期刊论文数量(31)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
川原正博: "βアミロイドの多量体化と神経毒住メカニズム"Molecular Medicine. 37. 1016-1028 (2000)
Masahiro Kawahara:“β-淀粉样蛋白多聚化和神经毒性机制”《分子医学》37. 1016-1028 (2000)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Kawahara M.: "Neurotoxicity of aluminum and its implication in neurodegenerative disease"Biomed. Res. Trace Elements. 12. 207-216 (2001)
Kawahara M.:“铝的神经毒性及其对神经退行性疾病的影响”Biomed。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
KAWAHARA M, KURODA Y: "Molecular mechanism of neurodegeneration induced by Alzheimer's β-amyloid protein : channel formation and disruption of calcium homeostasis"Brain Res. Bull. 53. 389-397 (2000)
KAWAHARA M、KURODA Y:“阿尔茨海默病 β-淀粉样蛋白诱导的神经变性的分子机制:钙稳态的形成和破坏”Brain Res. 53. 389-397 (2000)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
川原正博、黒田洋一郎: "アルツハイマー・βアミロイド蛋白質の神経毒性と膜脂質との関連"蛋白質、核酸、酵素. 44. 1982-1987 (1999)
Masahiro Kawahara、Yoichiro Kuroda:“阿尔茨海默病 β-淀粉样蛋白的神经毒性及其与膜脂质的关系”《蛋白质、核酸、酶》44。1982-1987 (1999)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
KAWAHARA M, KURODA Y: "Intracellular calcium changes in neuronal cells induced by Alzheimer's beta-amyloid protein are blocked by estradiol and cholesterol"Cellular and Molecular Neurobiology. 21. 1-13 (2001)
KAWAHARA M、KURODA Y:“阿尔茨海默病 β-淀粉样蛋白诱导的神经元细胞内钙变化被雌二醇和胆固醇阻断”《细胞和分子神经生物学》。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KAWAHARA Masahiro其他文献

KAWAHARA Masahiro的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('KAWAHARA Masahiro', 18)}}的其他基金

Development of a platform technology for intracellular drug discovery
细胞内药物发现平台技术的开发
  • 批准号:
    18H01792
  • 财政年份:
    2018
  • 资助金额:
    $ 1.98万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Analysis of leukemogenesis through the NPM fusion gene
通过 NPM 融合基因分析白血病发生
  • 批准号:
    24790971
  • 财政年份:
    2012
  • 资助金额:
    $ 1.98万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Screening of protein-protein interactions based on a growth signal of mammalian cells
基于哺乳动物细胞生长信号筛选蛋白质-蛋白质相互作用
  • 批准号:
    23656516
  • 财政年份:
    2011
  • 资助金额:
    $ 1.98万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Development of antibody screening system in mammalian cells using chimeric receptors
使用嵌合受体开发哺乳动物细胞中的抗体筛选系统
  • 批准号:
    21686077
  • 财政年份:
    2009
  • 资助金额:
    $ 1.98万
  • 项目类别:
    Grant-in-Aid for Young Scientists (A)
Molecular mechanism of zinc-induced neurotoxicity : involvement of Ca and ER stress
锌诱导神经毒性的分子机制:Ca 和 ER 应激的参与
  • 批准号:
    21590145
  • 财政年份:
    2009
  • 资助金额:
    $ 1.98万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Involvement of calcium homeostasis in the apoptotic neuronal death induced by zinc
钙稳态参与锌诱导的神经元凋亡
  • 批准号:
    19590133
  • 财政年份:
    2007
  • 资助金额:
    $ 1.98万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Formation of ion chyannels by amyloidogenic proteins and screening for protective substances
淀粉样蛋白形成离子通道及保护物质的筛选
  • 批准号:
    14572106
  • 财政年份:
    2002
  • 资助金额:
    $ 1.98万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似海外基金

Advancement of Prion Protein-Lowering Divalent siRNA Therapy for Prion Disease
朊病毒蛋白降低二价 siRNA 治疗朊病毒病的进展
  • 批准号:
    10721465
  • 财政年份:
    2023
  • 资助金额:
    $ 1.98万
  • 项目类别:
Measuring neural replay using magnetoencephalography (MEG); use as a biomarker in human prion disease
使用脑磁图(MEG)测量神经重放;
  • 批准号:
    MR/X019586/1
  • 财政年份:
    2023
  • 资助金额:
    $ 1.98万
  • 项目类别:
    Fellowship
Activation of Neuronal Degradative Pathways to Ameliorate Prion Disease
激活神经元降解途径以改善朊病毒病
  • 批准号:
    10855708
  • 财政年份:
    2023
  • 资助金额:
    $ 1.98万
  • 项目类别:
Therapeutic editing to lower PrP in prion disease: Administrative Core
降低朊病毒病中 PrP 的治疗性编辑:管理核心
  • 批准号:
    10669492
  • 财政年份:
    2023
  • 资助金额:
    $ 1.98万
  • 项目类别:
Therapeutic Editing to Lower PrP in Prion Disease
降低朊病毒病中 PrP 的治疗性编辑
  • 批准号:
    10669491
  • 财政年份:
    2023
  • 资助金额:
    $ 1.98万
  • 项目类别:
Prion Disease Research
朊病毒病研究
  • 批准号:
    CRC-2017-00288
  • 财政年份:
    2022
  • 资助金额:
    $ 1.98万
  • 项目类别:
    Canada Research Chairs
Conformational properties of misfolded protein aggregates in cases involving the co-occurrence of prion disease and Alzehimer's disease or prion disease and CTE
涉及朊病毒病和阿尔茨海默病或朊病毒病和 CTE 同时发生的情况下错误折叠蛋白聚集体的构象特性
  • 批准号:
    10682584
  • 财政年份:
    2022
  • 资助金额:
    $ 1.98万
  • 项目类别:
Conformational properties of misfolded protein aggregates in cases involving the co-occurrence of prion disease and Alzehimer's disease or prion disease and CTE
朊病毒病和阿尔茨海默病或朊病毒病和 CTE 同时发生的情况下错误折叠蛋白聚集体的构象特性
  • 批准号:
    10664201
  • 财政年份:
    2022
  • 资助金额:
    $ 1.98万
  • 项目类别:
How substrate dosage drives prion disease kinetics
底物剂量如何驱动朊病毒疾病动力学
  • 批准号:
    10344724
  • 财政年份:
    2021
  • 资助金额:
    $ 1.98万
  • 项目类别:
Development of Prion Protein-Lowering Divalent siRNA Therapy for Prion Disease
开发针对朊病毒病的降低朊病毒蛋白的二价 siRNA 疗法
  • 批准号:
    10549815
  • 财政年份:
    2021
  • 资助金额:
    $ 1.98万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了